Hemolytic Anemia and Red-Cell Destruction

Hemolytic anemia is the family of anemias caused by premature destruction of red blood cells, in which the bone marrow cannot fully compensate for the shortened red-cell lifespan. This reference area orients the reader to how red cells are destroyed (intravascular versus extravascular), the inherited and acquired causes, and the laboratory signature of accelerated red-cell turnover.

Definition

Hemolytic anemia is anemia resulting from increased red-blood-cell destruction (hemolysis) that exceeds the marrow's compensatory capacity, regardless of whether the underlying defect is intrinsic to the red cell or extrinsic to it.

Scope

The area groups the principal hemolytic disorders encountered in hematopathology and transfusion medicine: immune-mediated destruction (autoimmune hemolytic anemia and hemolytic disease of the fetus and newborn), inherited red-cell defects (membrane disorders, enzyme deficiencies such as G6PD, and hemoglobinopathies), and the laboratory framework used to recognize and differentiate hemolysis. It treats these as classification and reference topics, not as clinical management protocols.

Sub-topics

• Autoimmune Hemolytic Anemia (Warm and Cold Agglutinin Disease)
• G6PD Deficiency and Hemoglobinopathies
• Laboratory Diagnosis of Hemolytic Anemia: Hemolytic Markers and Differential
• Hemolytic Disease of the Fetus and Newborn (Erythroblastosis Fetalis)
• Hereditary Red-Cell Membrane Disorders (Spherocytosis, Elliptocytosis)

Core questions

• Is the hemolysis predominantly intravascular or extravascular, and what laboratory pattern distinguishes them?
• Is the cause intrinsic to the red cell (membrane, enzyme, or hemoglobin) or extrinsic (immune, mechanical, infectious)?
• Is the direct antiglobulin (Coombs) test positive, separating immune from non-immune hemolysis?

Key concepts

• Intravascular versus extravascular hemolysis
• Intrinsic versus extrinsic red-cell defects
• Reticulocytosis and marrow compensation
• Hemolytic markers (LDH, haptoglobin, indirect bilirubin)
• Direct antiglobulin (Coombs) test
• Inherited versus acquired hemolysis

Mechanisms

Red cells normally survive about 120 days; in hemolytic anemia survival is shortened and destruction may occur within the circulation (intravascular hemolysis, releasing free hemoglobin and consuming haptoglobin) or within the mononuclear phagocyte system of the spleen and liver (extravascular hemolysis). The destruction may follow an intrinsic red-cell defect — a membrane abnormality, an enzyme deficiency such as glucose-6-phosphate dehydrogenase deficiency, or a structural hemoglobin disorder — or an extrinsic insult such as antibody binding, mechanical fragmentation, or infection. Whatever the cause, the shared laboratory signature is increased lactate dehydrogenase, reduced or absent haptoglobin, raised unconjugated bilirubin, and a reticulocyte response reflecting marrow attempts at compensation, as reviewed in the differential-diagnosis literature (barcellini-2015).

Clinical relevance

Recognizing the pattern of hemolysis and classifying its cause underlies the diagnostic workup of anemia in hematology and transfusion medicine. This area describes how hemolytic disorders are categorized and how their laboratory footprints are read; it is reference and educational material and is not a basis for individual diagnostic or treatment decisions.

Epidemiology

The relative frequency of hemolytic causes varies geographically: inherited disorders such as G6PD deficiency and hemoglobinopathies are common where malaria is or was endemic, reflecting a protective selective advantage (luzzatto-2020), whereas autoimmune hemolytic anemia and hemolytic disease of the newborn are encountered across populations and shaped by transfusion and antenatal-care practices.

Evidence & guidelines

International consensus recommendations exist for the diagnosis and treatment of autoimmune hemolytic anemia in adults (jager-2020), and dedicated reviews summarize hemolytic markers (barcellini-2015), red-cell membrane disorders (narla-2017), and enzyme defects (luzzatto-2020); these are descriptive references rather than prescriptive instructions.

Seminal works

• barcellini-2015
• jager-2020
• luzzatto-2020

Frequently asked questions

What distinguishes intravascular from extravascular hemolysis?

Intravascular hemolysis destroys red cells within the bloodstream, releasing free hemoglobin and markedly depleting haptoglobin, often with hemoglobinuria; extravascular hemolysis removes red cells through the spleen and liver and produces a more gradual rise in bilirubin with less free hemoglobin.

Why is the direct antiglobulin (Coombs) test central to classifying hemolytic anemia?

A positive test indicates antibody or complement bound to the red cells, pointing to an immune mechanism, while a negative test directs attention to intrinsic defects (membrane, enzyme, or hemoglobin) or non-immune extrinsic causes.